CXCL8 and breast cancer: The outcomes displayed that the biomarkers strongly involved in the inflammatory cellular response, such as IL-6, IL-8 and MCAF, were significantly reduced by BC and all CS treatments, thus highlighting a generally positive anti-inflammatory effect [50,51].